BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11454712)

  • 1. Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin.
    Isogai C; Laug WE; Shimada H; Declerck PJ; Stins MF; Durden DL; Erdreich-Epstein A; DeClerck YA
    Cancer Res; 2001 Jul; 61(14):5587-94. PubMed ID: 11454712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation.
    Kjøller L; Kanse SM; Kirkegaard T; Rodenburg KW; Rønne E; Goodman SL; Preissner KT; Ossowski L; Andreasen PA
    Exp Cell Res; 1997 May; 232(2):420-9. PubMed ID: 9168821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis.
    Leik CE; Su EJ; Nambi P; Crandall DL; Lawrence DA
    J Thromb Haemost; 2006 Dec; 4(12):2710-5. PubMed ID: 17010152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of apoptosis in vascular cells by plasminogen activator inhibitor-1 and high molecular weight kininogen correlates with their anti-adhesive properties.
    Al-Fakhri N; Chavakis T; Schmidt-Wöll T; Huang B; Cherian SM; Bobryshev YV; Lord RS; Katz N; Preissner KT
    Biol Chem; 2003 Mar; 384(3):423-35. PubMed ID: 12715893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of plasminogen activator inhibitor-1-specific RNA aptamers on cell adhesion, motility, and tube formation.
    Brandal S; Blake CM; Sullenger BA; Fortenberry YM
    Nucleic Acid Ther; 2011 Dec; 21(6):373-81. PubMed ID: 22103403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor-1 inhibits angiogenic signaling by uncoupling vascular endothelial growth factor receptor-2-αVβ3 integrin cross talk.
    Wu J; Strawn TL; Luo M; Wang L; Li R; Ren M; Xia J; Zhang Z; Ma W; Luo T; Lawrence DA; Fay WP
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):111-20. PubMed ID: 25378411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor type 1 promotes fibrosarcoma cell migration by modifying cellular attachment to vitronectin via alpha(v)beta(5) integrin.
    Takahashi T; Suzuki K; Ihara H; Mogami H; Kazui T; Urano T
    Semin Thromb Hemost; 2005 Jun; 31(3):356-63. PubMed ID: 16052409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plasminogen-plasminogen activator (PA) system in neuroblastoma: role of PA inhibitor-1 in metastasis.
    Sugiura Y; Ma L; Sun B; Shimada H; Laug WE; Seeger RC; DeClerck YA
    Cancer Res; 1999 Mar; 59(6):1327-36. PubMed ID: 10096567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody.
    Sheu JR; Yen MH; Kan YC; Hung WC; Chang PT; Luk HN
    Biochim Biophys Acta; 1997 Oct; 1336(3):445-54. PubMed ID: 9367172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies.
    Bajou K; Masson V; Gerard RD; Schmitt PM; Albert V; Praus M; Lund LR; Frandsen TL; Brunner N; Dano K; Fusenig NE; Weidle U; Carmeliet G; Loskutoff D; Collen D; Carmeliet P; Foidart JM; Noël A
    J Cell Biol; 2001 Feb; 152(4):777-84. PubMed ID: 11266468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin.
    Waltz DA; Natkin LR; Fujita RM; Wei Y; Chapman HA
    J Clin Invest; 1997 Jul; 100(1):58-67. PubMed ID: 9202057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis.
    Chavakis T; Cines DB; Rhee JS; Liang OD; Schubert U; Hammes HP; Higazi AA; Nawroth PP; Preissner KT; Bdeir K
    FASEB J; 2004 Aug; 18(11):1306-8. PubMed ID: 15208269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrillar collagen regulation of plasminogen activator inhibitor-1 is involved in altered smooth muscle cell migration.
    Tanaka S; Koyama H; Ichii T; Shioi A; Hosoi M; Raines EW; Nishizawa Y
    Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1573-8. PubMed ID: 12377732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling.
    Stefansson S; McMahon GA; Petitclerc E; Lawrence DA
    Curr Pharm Des; 2003; 9(19):1545-64. PubMed ID: 12871067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitronectin decreases microvascular endothelial cell apoptosis.
    Isik FF; Gibran NS; Jang YC; Sandell L; Schwartz SM
    J Cell Physiol; 1998 May; 175(2):149-55. PubMed ID: 9525473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cells inhibit flow-induced smooth muscle cell migration: role of plasminogen activator inhibitor-1.
    Redmond EM; Cullen JP; Cahill PA; Sitzmann JV; Stefansson S; Lawrence DA; Okada SS
    Circulation; 2001 Jan; 103(4):597-603. PubMed ID: 11157728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human endothelial cells grow poorly on vitronectin: role of PAI-1.
    Underwood PA; Bean PA; Cubeddu L
    J Cell Biochem; 2001 Apr 2-27; 82(1):98-109. PubMed ID: 11400167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor type-1 mutants regulate angiogenesis of human umbilical and lung vascular endothelial cells.
    Chorostowska-Wynimko J; Swiercz R; Skrzypczak-Jankun E; Selman SH; Jankun J
    Oncol Rep; 2004 Dec; 12(6):1155-62. PubMed ID: 15547731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor-1 and -3 increase cell adhesion and motility of MDA-MB-435 breast cancer cells.
    Palmieri D; Lee JW; Juliano RL; Church FC
    J Biol Chem; 2002 Oct; 277(43):40950-7. PubMed ID: 12176977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential.
    Brodsky SV; Malinowski K; Golightly M; Jesty J; Goligorsky MS
    Circulation; 2002 Oct; 106(18):2372-8. PubMed ID: 12403669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.